-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, REP5imwz8jG0bHBMdlQ8xe9eK9s+33VbEHreNAGjkCg6McbA7E8XOxu4SeUATMRV VIMvgFlWjhxcn5vT6zp19w== 0000950136-04-000437.txt : 20040217 0000950136-04-000437.hdr.sgml : 20040216 20040217132447 ACCESSION NUMBER: 0000950136-04-000437 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: APAX PARTNERS INC CENTRAL INDEX KEY: 0000938219 IRS NUMBER: 132647531 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127536300 MAIL ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: PATRICOF & CO VENTURES INC DATE OF NAME CHANGE: 19950315 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VICURON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001052547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043278032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60747 FILM NUMBER: 04606583 BUSINESS ADDRESS: STREET 1: 455 SOUTH GULPH ROAD STREET 2: SUITE 305 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 610-491-2200 MAIL ADDRESS: STREET 1: 455 SOUTH GULPH ROAD STREET 2: SUITE 305 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: VERSICOR INC /CA DATE OF NAME CHANGE: 20000321 SC 13G/A 1 file001.txt SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3)* VICURON PHARMACEUTICALS INC. -------------------------------------------------------------- (Name of Issuer) COMMON STOCK -------------------------------------------------------------- (Title of Class of Securities) 926471103 -------------------------------------------------------------- (CUSIP Number) DECEMBER 31, 2003 -------------------------------------------------------------- Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - -------------------------------------------------------------------------------------------------------------------- CUSIP NO. 926471103 PAGE 2 OF 6 PAGES - -------------------------------------------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Apax Partners, Inc. 13-2647531 - -------------------------------------------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 1,200,961* REPORTING -------------------------------------------------------------------------------------------- PERSON WITH 7. SOLE DISPOSITIVE POWER 0 -------------------------------------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,200,961* - -------------------------------------------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,200,961* - -------------------------------------------------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] N/A - -------------------------------------------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.2% - -------------------------------------------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (See Instructions) CO - --------------------------------------------------------------------------------------------------------------------
*See Rider A Page 3 of 6 Pages Item 1. (a) Name of Issuer: Vicuron Pharmaceuticals Inc. (b) Address of Issuer's Principal Executive Offices: 455 South Gulph Road, Suite 305 King of Prussia, PA 19406 Item 2. (a) Name of Person Filing: Apax Partners, Inc. (b) Address of Principal Business Office or, if none, Residence: 445 Park Avenue, 11th Floor New York, NY 10022 (c) Citizenship: New York (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 926471103 Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940. (e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G). (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940. (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). Page 4 of 6 Pages Item 4. Ownership. (a) Amount beneficially owned: 1,200,961* (b) Percent of class: 2.2% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 (ii) Shared power to vote or to direct the vote 1,200,961* (iii) Sole power to dispose or to direct the disposition of 0 (iv) Shared power to dispose or to direct the disposition of 1,200,961* *See Rider A Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. Page 5 of 6 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 3, 2004 /s/ George M. Jenkins - ------------------ --------------------- (Date) (Signature) George M. Jenkins / Vice President ---------------------------------- (Name/Title) The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties for whom copies are to be sent. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) Page 6 of 6 Pages Rider A As of December 31, 2003, Apax Partners, Inc. ("Apax") may be deemed to be the beneficial owner of 1,186,566 shares of common stock (1.98%) owned by APA Excelsior V, L.P., a Delaware Limited Partnership, and 14,395 shares of common stock (0.02%) owned by Patricof Private Investment Club II, L.P., a Delaware Limited Partnership. Each of such entities is managed or advised by Apax and, as such, Apax may be deemed to have shared voting and dispositive power with the General Partners of each Partnership with respect to an aggregate of 1,200,961 shares of common stock. This filing does not include 750,521 shares of common stock owned by funds managed or advised by Apax Partners & Co. Ltd. and its affiliates. -----END PRIVACY-ENHANCED MESSAGE-----